Return to search

IPO Profile: Capnia Inc

Company Details

Palo Alto, Calif.


Description: Capnia develops medical diagnostics and therapeutics based on its technology for precision metering of gas flow. The company’s first product, CoSense, aids in the diagnosis of hemolysis in neonates, a dangerous condition in which red blood cells degrade rapidly, which can lead to long-term developmental disability.

IPO Details

Exchange and Ticker: Nasdaq: CAPN

Filing Range: 1.55 million shares @ $6.50 to $6.50

Offering Price: $6.50

Close price as of 11/13/14: $3.88

Offering Size: $10.7M

Shares Outstanding: N/A

Underwriters: Maxim Group LLC

Co-manager: Dawson James Securities

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Loeb & Loeb

Auditor: Marcum & Kliegman LLP

Market Capitalization on 11/28/14: N/A

Close price at current month end: $3.33

Investment Details

Venture Backers: Vivo Ventures, Asset Management Ventures, Teknoinvest AS, Alliance Venture AS


  • 7/1/00 $100K
  • 6/14/01 $1.75M
  • 10/1/01 $1.8M
  • 5/4/04 $12M
  • 9/29/06 $955K
  • 10/21/06 $2M
  • 3/31/08 $23.6M
  • 6/26/08 $50K

Source: Thomson Reuters data